Verified factor-similar pair

USVM vs XSMO

These two ETFs meet the same FF6 US comparison criteria: US-listed equity ETFs, the same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.

SMB UMD
Similarity score
85
Verified similar

The score combines exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.

Quick Read

  • USVM has the higher backtested relative Sharpe (1.046 vs 1.041).
  • USVM has the lower published fee (0.29% vs 0.36%).
  • USVM is cheaper on dividend valuation (79 vs 126, where 100 is each fund's historical median).
  • USVM has the stronger regression fit (adjusted R-squared 0.962 vs 0.903).

These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.

USVM

VictoryShares US Small Mid Cap Value Momentum ETF
SMB UMD
Adj. R2
0.962
Rel. Sharpe
1.046
Mkt beta
0.97
AUM
US$1.5B
MER
0.29%
Valuation
79

XSMO

Invesco S&P SmallCap Momentum ETF
SMB UMD
Adj. R2
0.903
Rel. Sharpe
1.041
Mkt beta
0.99
AUM
US$2.5B
MER
0.36%
Valuation
126

Factor Exposure Match

Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.

SMB
USVM
+0.79
|t|
+16.5
XSMO
+0.84
|t|
+17.4
diff -0.05
HML
USVM
+0.20
|t|
+4.8
XSMO
+0.03
|t|
+0.5
diff +0.17
RMW
USVM
+0.15
|t|
+2.9
XSMO
+0.03
|t|
+0.6
diff +0.12
CMA
USVM
+0.01
|t|
+0.2
XSMO
-0.04
|t|
-0.6
diff +0.06
UMD
USVM
+0.14
|t|
+4.2
XSMO
+0.22
|t|
+7.7
diff -0.08

Why This Pair Matches

Exposure level
80
Exposure shape
98
Mkt beta diff
0.02
Rel. Sharpe diff
0.006

This comparison focuses on measured factor exposure. It does not compare holdings methodology, turnover, tax handling, or issuer process. Backtested relative Sharpe is a secondary signal rather than a stand-alone forecast. See methodology.

USVM fund page XSMO fund page US ETF Leaders US Universe
Important context

VerifiedBeta publishes educational ETF research, not personalized investment advice, portfolio management, or security recommendations. Funds that screen well here can still be unsuitable for your objectives, taxes, liquidity needs, or constraints. Review fund documents, methodology assumptions, and your own circumstances before acting. See the full disclaimer.